Targeting Lgr5+ cells to treat colon cancer has been a topic of interest, as these cells have demonstrated the potential to be the origin of some intestinal tumors[10]; thus, we aim to thoroughly discuss the latest therapeutic strategies that target Lgr5+ cells. The gene discussed is LGR5; the disease is intestinal neoplasm.